Concepedia

William Neway

WN

Statistics

Publications

11

Citations

675

H-Index

11

Active since

2000

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Yale University

William Neway is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug metabolism.

ORCID

Publications per year

2000–2015

11

Publications

11

In Vitro Substrate Identification Studies for P-glycoprotein-Mediated Transport: Species Difference and Predictability of in Vivo Results

Masayo Yamazaki, William Neway, Tomoyuki Ohe et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 237 citations

, , +14

A Rational Utilization of High-Throughput Screening Affords Selective, Orally Bioavailable 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonists

Jeffrey J. Hale, Christopher L. Lynch, William Neway et al. · Journal of Medicinal Chemistry · 2004 · 88 citations · Full text

, , +9

Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720

Jeffrey J. Hale, William Neway, Sander G. Mills et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 73 citations · Full text

, , +6

P450 interaction with HIV protease inhibitors: relationship between metabolic stability, inhibitory potency, and P450 binding spectra.

Masato Chiba, Lixia Jin, William Neway et al. · PubMed · 2001 · 71 citations

, , +17

Sphingosine 1-phosphate receptor agonist FTY720-phosphate causes marginal zone B cell displacement

Kalpit A. Vora, E.A. Nichols, Gene Porter et al. · Journal of Leukocyte Biology · 2005 · 57 citations

, , +17

1–5 of 11